Helius Medical Technologies reports compliance with Nasdaq equity requirements By Investing.com Helius Medical Technologies reports compliance with Nasdaq equity requirements…
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”),…
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a…
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference…
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) NEWTOWN, Pa., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results Company to host call at 4:30pm today Company to host call at 4:30pm today…
Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts -- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple…
Ausblick: Helius Medical Technologies A informiert über die jüngsten Quartalsergebnisse Helius Medical Technologies A öffnet am 13.05.2024 die Bücher zum am 31.03.2024 abgelaufenen Quartal.1 Analyst schätzt, dass Helius Medical …
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”),…
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”),…
Earnings call: Helius Medical Technologies outlines reimbursement strategy By Investing.com Earnings call: Helius Medical Technologies outlines reimbursement strategy…
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results -- Company to host call at 4:30pm today -- NEWTOWN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Helius…